In 2017, Cann Pharma was issued with one of Australia's early licenses for Medicinal Cannabis Cultivation and Production from the Office of Drugs Control (ODC).

The Company has applied for its own license for manufacturing of medicinal cannabis products. We also hold key agreements with stakeholders to enable us to undertake research.

Our intellectual property and our large, existing medical product portfolio and technology provide a platform to fast track production and ultimate access of our pharmaceutical products in Australia to address the unmet medical needs of patients and physicians.

Cann Pharma is well advanced with its strategy of securing additional licenses and permits.